China Contraceptive Devices Market Report 2022 to 2030

China Contraceptive Devices Market Analysis

$ 3999

China's Contraceptive Devices Market is expected to witness growth from $1037 Mn in 2022 to $2143 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. In China, there is an increasing demand for contraceptive methods due to a growing understanding of the advantages of family planning. This is influenced by things like rising urbanization, women's emancipation, and government programs to slow population increase. The market is segmented by type and by gender. Some key players in this market include Suzhou Medical Supplies, Xian Janssen Pharmaceutical, Mylan Laboratories, Shenzhen Huikang Medical Apparatus, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

ID: IN10CNMD005 CATEGORY: Medical Devices GEOGRAPHY: China AUTHOR: Jigyasu Bhandari

Buy Now

China Contraceptive Devices Healthcare Market Executive Analysis

China's Contraceptive Devices Market size is at around $1037 Mn in 2022 and is projected to reach $2143 Mn in 2030, exhibiting a CAGR of 9.50% during the forecast period. As of February 2023, China had spent $47.35 billion on healthcare and family planning. This indicates a rise in comparison to earlier projections of $28.02 Bn for November 2022. The data hit a new low of $0.86 billion in January 2007 before reaching a peak of $47.35 billion in February 2023. In 2022, China's health spending accounted for 5.4% of the GDP. China's health spending as a share of GDP increased from 5.2% in 2015 to 5.4% in 2022.

In China, there were 23 maternal fatalities for every 100,000 live births in 2021. In China, there were 27.9 million new cases of sexually transmitted infections in 2021, a rise of 12.5% from the number of new cases in 2013. In China, contraceptive and birth control methods are often used to avoid unexpected pregnancies. Condoms, intrauterine devices, contraceptive tablets, contraceptive patches, vaginal rings, and contraceptive injections are a few of the most widely used contraceptive methods in China. The use of contraceptive methods can help minimise the need for abortions and enhance maternal and child health outcomes since they are very successful at avoiding unplanned pregnancies. With the help of contraceptive methods, women can better manage their reproductive health and make decisions about their futures and bodies. There are several options available for contraceptive methods that can be tailored to fit various needs, interests, and lifestyles. For instance, although some women might like oral contraceptives or condoms, others could favour long-acting options like IUDs. Even in rural or remote regions, contraceptive devices can be widely available and accessible, making them a crucial tool for enhancing access to family planning services.

China Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In China, there is an increasing demand for contraceptive methods due to a growing understanding of the advantages of family planning. This is influenced by things like rising urbanisation, women's emancipation, and government programmes to slow population increase. Due to China's high STI incidence, the demand for condoms and other barrier methods of contraception has increased. These methods are very successful at stopping the spread of STIs. Contraceptive methods are now more widely available and practical for customers thanks to the growth of distribution channels like e-commerce and online pharmacies. This has raised consumer interest in these products, particularly among women and young adults in metropolitan locations.

Market Restraints

In China, some people could be discouraged from utilising contraceptive methods due to conventional beliefs and societal conventions surrounding sex and contraception. In addition, some women may encounter opposition from their families or partners when attempting to obtain or utilise these drugs. Traditional methods of contraception, such as withdrawal or calendar methods, are still widely used in some regions. Due to cultural or socioeconomic factors, lack of access to healthcare services or contraceptive options, or other factors, these methods may be favoured.

Competitive Landscape

Key Players

Suzhou Medical Supplies (CN)
Beijing Huacheng Jinke Technology (CN)
Shenzhen Huikang Medical Apparatus (CN)
Xian Janssen Pharmaceutical (CN)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Recent Notable Deals

2022: Bayer AG announced in 2022 that Xian Janssen Pharmaceutical Ltd. of China would purchase its Women's Health division. Yaz, Yasmin, and Mirena were among the contraceptive devices sold by Bayer as part of the deal.

Healthcare Policies and Regulatory Landscape

In China, for contraceptive devices, the Chinese government has established a regulatory framework. Before selling their goods in China, manufacturers must have regulatory permission from the National Medical Products Administration (NMPA). The "One-Child Policy" in China, also known as the "Family Planning Policy," was put into effect in 1979 and limited the number of children that a family could have. Despite the policy's relaxation in 2015 to permit two children per household, it still has a considerable impact on Chinese consumers' desire for and adoption of contraceptive methods. Manufacturers in China are required to receive Good Manufacturing Practice (GMP) certification in order to guarantee the security and calibre of contraceptive devices. Manufacturers must follow stringent quality control and production requirements in order to receive this certification, which is given by the NMPA. The Chinese government has compiled a list of essential medications that it believes are required for its healthcare system, known as the National Essential Medicines List (NEML). Some contraception methods, including IUDs and contraceptive implants, are listed on the NEML and receive government subsidies to lower their cost to users.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.